NexGenEsis Healthcare – Jersey Village offers umbilical cord–derived biologic products (e.g., Wharton’s jelly–based preparations) as an elective option for select patients who’ve tried standard care and want to explore advanced regenerative strategies within a realistic, stepwise plan.

What this means

After a candidacy review (history, exam, imaging), we discuss whether a cord-derived biologic injection—performed under image guidance—might support symptom relief and function as part of a broader program that includes load management, targeted exercise, sleep/nutrition basics, and, when appropriate, other therapies (PRP, BMAC, ESWT, Class IV laser).

What we tell you up front

• These therapies are not FDA-approved for many orthopedic uses people hope to treat.
• They are elective and self-pay.
• Outcomes are not guaranteed; responses vary and some patients do not improve.
• We will compare this path with PRP, BMAC, or non-injection strategies (PT, weight management, activity modifications) and may advise against biologics if they aren’t in your best interest.

Safety & expectations
We review medical history, medications, and goals, outline risks (pain, bruising, rare infection), set measurable milestones, and stop or pivot if progress isn’t on track. No hype—just clear trade-offs and next steps.

If you’re evaluating advanced regenerative options around Houston, schedule a consultation at NexGenEsis Healthcare – Jersey Village to go over umbilical cord–derived therapies in straightforward terms and see if they belong in your plan.